Indrayani Biotech: Board Meeting Outcome for Board Meeting Outcome For Adoption Of Unaudited Standalone And Consolidated Financial Results For The Quarter Half Year Ended September 2025

Indrayani Biotech Ltd has informed BSE that the meeting of the Board of Directors inter alia to consider and approve unaudited financial results (standalone and consolidated) for quarter and Half year ended 30th September 2025 has been postponed.